Qutenza® is indicated for the management of neuropathic pain associated with postherpetic neuralgia.
In clinical studies, serious adverse reactions included application–associated pain and increase in blood pressure. The most common adverse reactions (≥ 5% and greater than control) were application-site erythema, application-site pain, application-site pruritus, and application-site papules.
I:Q Practice Referral Optimization (PRO) is designed to help physicians reach out to patients who may benefit from Qutenza® treatment. Below are downloadable materials and tools that you can use to inform patients and your colleagues that you offer Qutenza® treatment. Also, be sure to join Qutenza® Find A Doctor to help potential Qutenza® patients find you.
The materials below are customizable. You can add the name of your practice, use your own letterhead, insert the names of your patients or colleagues, and more, to personalize.
Please note that the two materials shown below are only available through your Qutenza® representative, so contact your rep today. Click the images to enlarge for viewing.
Should you have any questions or require additional assistance, please contact your NeurogesX Product Representative at 877-900-NGSX (6479) or the I:Q Training Program at 888-YOU-LRNQ (968-5767).